Knowing that the drug is meant for hypertension patients, spironolactone could be beneficial as a Panx-1 blocker in the context of COVID-19 (Aoumari et al., 1990; Bennett and Zukin, 2004). The gene discussed is PANX1; the disease is COVID-19.